Skip to main content
. 2021 May 31;30(8):1535–1553. doi: 10.1002/pro.4125

FIGURE 5.

FIGURE 5

Allosteric MEK inhibitors. (a) Structure of the MEK1 kinase in its inactive state in complex with early MEK inhibitor PD318088 and Mg2+ ATP. The inhibitor and ATP are shown in spacefill to indicate the respective locations of the ATP and allosteric inhibitor binding sites (PDB ID 1S9J). 107 (b) Detailed view of inhibitor interactions in the structure shown in Panel A. (c) Crystal structure of a MEK1: BRAF dimer, with inhibitor GDC‐0623 bound in the MEK allosteric site (PDB ID 6PP9). 77 (d) Detail of the interactions of GDC‐0623 in the MEK allosteric site. (e) Crystal structure of a KSR:MEK1 dimer, with inhibitor trametinib bound in the MEK allosteric site (PDB ID 7JUX). 108 (f) Detailed view of the interactions of trametinib in the MEK1 allosteric site